TARDBP and amyotrophic lateral sclerosis: Thus, strategies to solubilize TDP43, such as antisense oligonucleotides67 or small molecule inhibitors26,68 that prevent the accumulation and aggregation of TDP43, may also restore splicing defects in ALS patients.